Quick Answer
Renalytix plc reported Total Revenue of $2.29 million for fiscal year 2024.
Renalytix plc — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.29M -32.7% |
$3.40M +14.6% |
$2.97M +99.2% |
$1.49M | $0.00 | — |
| Net Income | -$33.46M +26.6% |
-$45.61M -0.7% |
-$45.28M -28.1% |
-$35.34M -259.0% |
-$9.84M +76.7% |
-$42.30M |
| Diluted EPS | -$0.31 +43.6% |
-$0.55 +17.9% |
-$0.67 -36.7% |
-$0.49 -188.2% |
-$0.17 | — |
| Total Assets | $7.97M -74.0% |
$30.63M -38.8% |
$50.06M -36.3% |
$78.58M +276.3% |
$20.88M +115.3% |
$9.70M |
| Cash and Equivalents | $4.68M -81.0% |
$24.68M -40.3% |
$41.33M -36.5% |
$65.13M +389.9% |
$13.29M +62.1% |
$8.20M +9901.2% |
| Stockholders Equity | -$7.85M -212.7% |
$6.97M -77.2% |
$30.61M -57.2% |
$71.46M +349.1% |
$15.91M +86.1% |
$8.55M +1803.4% |
| Operating Income | -$29.61M +29.9% |
-$42.22M +20.6% |
-$53.18M -66.6% |
-$31.92M -209.4% |
-$10.31M +75.6% |
-$42.34M |
| Gross Profit | $156.0K -78.3% |
$720.0K -17.6% |
$874.0K +38.1% |
$633.0K | $0.00 | — |
| Shares Outstanding | 154.37M +64.6% |
93.78M +25.4% |
74.76M +3.6% |
72.20M +21.5% |
59.42M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2024 | $522.0K | +13.7% | -2.4% |
| Net Income | September 30, 2024 | -$4.73M | +53.4% | +38.9% |
| Diluted EPS | September 30, 2024 | -$0.04 | +63.6% | +50.0% |
| Total Assets | September 30, 2024 | $4.79M | -75.5% | -39.9% |
| Cash and Equivalents | September 30, 2024 | $909.0K | -93.5% | -80.6% |
| Stockholders Equity | September 30, 2024 | -$11.32M | -659.2% | -44.1% |
| Operating Income | September 30, 2024 | -$4.09M | +54.0% | +37.5% |
| Gross Profit | September 30, 2024 | $100.0K | +332.6% | +251.5% |
| Shares Outstanding | September 30, 2024 | 165.93M | +76.9% | +7.5% |
- Renalytix plc reported Total Revenue of $2.29 million for fiscal year 2024.
- Renalytix plc showed a decrease of -32.7% in Total Revenue compared to the prior fiscal year.
- Renalytix plc reported Net Income of -$33.46 million for fiscal year 2024.
- Renalytix plc showed an increase of +26.6% in Net Income compared to the prior fiscal year.
- Renalytix plc reported Diluted EPS of $0.31 per share (loss) for fiscal year 2024.
- Renalytix plc showed an increase of +43.6% in Diluted EPS compared to the prior fiscal year.
- Renalytix plc reported Total Assets of $7.97 million for fiscal year 2024.
- Renalytix plc showed a decrease of -74.0% in Total Assets compared to the prior fiscal year.
- Renalytix plc reported Cash and Equivalents of $4.68 million for fiscal year 2024.
- Renalytix plc showed a decrease of -81.0% in Cash and Equivalents compared to the prior fiscal year.
- Renalytix plc reported Stockholders Equity of -$7.85 million for fiscal year 2024.
- Renalytix plc showed a decrease of -212.7% in Stockholders Equity compared to the prior fiscal year.
- Renalytix plc reported Operating Income of -$29.61 million for fiscal year 2024.
- Renalytix plc showed an increase of +29.9% in Operating Income compared to the prior fiscal year.
- Renalytix plc reported Gross Profit of $156.0 thousand for fiscal year 2024.
- Renalytix plc showed a decrease of -78.3% in Gross Profit compared to the prior fiscal year.
- Renalytix plc reported Shares Outstanding of 154.37 million shares for fiscal year 2024.
- Renalytix plc showed an increase of +64.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: